[Edaily Starin, Reporter Gim Ga Yeong ] Lee Jun-young is set to make his first public appearance in nine years on “Four Hands.”
In Episode 7 of the tvN Saturday-Sunday drama “Four Hands,” airing on the 19th, conductor Choi Jeong-yo (played by Lee Jun-young) will be seen giving a media interview. Previously, on the eve of the finals of an international competition, Choi Jeong-yo was kidnapped by mysterious figures. He struggled desperately to escape but was ultimately shot and fell into the river. With the subsequent investigation making little progress, Choi Jeong-yo’s whereabouts became even more unclear, and people in the music industry began to accept his death as a fait accompli, one by one. Just as pianist Choi Jeong-yo was about to fade from public memory, he took the stage at a competition to select the world’s best conductor under the name “Luca Domenico,” stunning everyone. Questions are piling up—from why he gave up his career as a pianist to take up the conductor’s baton to why he used a strange name instead of his own. Amid this, anticipation is building as a media interview with Choi Jeong-yo—in which his nine years of mysterious activities will finally come to light—has been announced. Unlike his past as a youthful student, a much more mature Choi Jeong-yo now draws attention with his composed gaze and dignified demeanor. During the interview, while Choi Jeong-yo answered the barrage of questions from the press, he reacted sensitively and remained silent whenever the conversation turned to the pianist Choi Jeong-yo. Curiosity is mounting about the circumstances behind his decision to conceal his past and the story he is hiding behind his silence. “Four Hands” is a drama that depicts the friendship, love, competition, and growth of young people who meet at an arts high school filled with musical prodigies. Actors Song Kang and Lee Jun-young star in the series. It airs every Saturday and Sunday at 9:10 p.m. on tvN.
This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …